27R

[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid

Find entries where: 27R

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
Synonyms	Bromfenac
Identifiers	2-[2-azanyl-3-(4-bromophenyl)carbonyl-phenyl]ethanoic acid
Formula	C₁₅ H₁₂ Br N O₃
Molecular Weight	334.165
Type	NON-POLYMER
Isomeric SMILES	c1cc(c(c(c1)C(=O)c2ccc(cc2)Br)N)CC(=O)O
InChI	InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)
InChIKey	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	32
Chiral Atom Count	0
Bond Count	33
Aromatic Bond Count	12

Drug Info: DrugBank

DrugBank ID	DB00963
Name	Bromfenac
Groups	approved withdrawn
Description	Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms	Bromfenacum Bromfenac sodium [2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid 2-amino-3-(4-bromobenzoyl)benzeneacetic acid Bromfenac Bromfenaco
Brand Names	Bromday Bromsite 0.075% Prolensa Xibrom Bromfenac Ophthalmic Solution Bromfenac Ophthalmic Solution 0.09% Pred-Brom Yellox Bromfenac Auro-bromfenac Bromfenac Sodium Pred-Gati-Brom Pred Phos-Gati-Brom Bromfenac Ophthalmic Solution, 0.09% Bromfenac 0.075% Apo-bromfenac Pred Phos - Brom
Indication	For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Categories	Agents causing hyperkalemia Analgesics Analgesics, Non-Narcotic Anti-Inflammatory Agents Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal (Non-Selective) Antirheumatic Agents Benzene Derivatives Central Nervous System Agents Cyclooxygenase Inhibitors Hydrocarbons, Brominated Hydrocarbons, Halogenated Ketones Nephrotoxic agents Ophthalmologicals Peripheral Nervous System Agents Selective Cyclooxygenase 2 Inhibitors (NSAIDs) Sensory Organs Sensory System Agents
ATC-Code	S01BC11
CAS number	91714-94-2

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Prostaglandin G/H synthase 2	MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...	unknown	inhibitor
Prostaglandin G/H synthase 1	MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG...	unknown	inhibitor
Prostaglandin G/H synthase 2	MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682